Elevated Expert Advice | Myeloma CAR T-Cell Therapy

https://vimeo.com/1164531878 Myeloma specialist Dr. Ciara Freeman shares hope for the future of myeloma care, encouraging patients and care partners to stay informed, ask bold questions, and connect with a myeloma…

Myeloma CAR T-Cell Therapy | Long-Term Recovery

https://vimeo.com/1164531893 Dr. Ciara Freeman, a myeloma specialist from Moffitt Cancer Center, discusses what to expect in the long term following the CAR T-cell therapy process. Dr. Freeman reviews symptoms to watch…

After CAR T-Cell Therapy | Essential Follow-Up & Testing

https://vimeo.com/1164531905 Can CAR T-cell therapy response deepen over time? Dr. Ciara Freeman, a myeloma specialist from Moffitt Cancer Center, discusses how the effectiveness of treatment is monitored over time, including the…

Research Updates From ASH | Myeloma CAR T-Cell Therapy

https://vimeo.com/1164531982 Myeloma expert and researcher Dr. Ciara Freeman shares key CAR T-cell therapy advances presented at the 2025 American Society of Hematology (ASH) meeting. Dr. Freeman also provides an explanation…

复发后的骨髓瘤:新研究对患者的意义

https://vimeo.com/1160266766 德克萨斯大学MD安德森癌症中心的Krina K. Patel医学博士讨论了MAJESTIC-3临床试验中令人鼓舞的新数据,该研究针对首次复发后的多发性骨髓瘤患者,评估了两种免疫疗法联合使用的效果。她解释了这种治疗方法的工作原理、为何研究结果如此令人振奋,以及为何支持性治疗对于安全管理治疗至关重要。Patel医生还分享了实用见解,帮助患者理解这一治疗选择在其整体治疗路径中的潜在定位,在带来希望的同时,强调经过深思熟虑的个体化决策的重要性。 See More from [ACT]IVATED Multiple Myeloma Related Resources What Are Myeloma Risk Factors for Veterans and First Responders? How AI Is Shaping the Future of CAR…

Share On:

Facebook
Twitter
LinkedIn